Journal of Virology, November 2002, p. 10674-10684, Vol. 76, No. 21
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.21.10674-10684.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Selection for Human Immunodeficiency Virus Type 1 Recombinants in a Patient with Rapid Progression to AIDS
Shan-Lu Liu,1,
John E. Mittler,1 David C. Nickle,1 Thera M. Mulvania,1,2 Daniel Shriner,1 Allen G. Rodrigo,1,3 Barry Kosloff,2 Xi He,1 Lawrence Corey,1,2,3,4 and James I. Mullins1,2,3*
Departments of Microbiology,1
Laboratory Medicine,2
Medicine, University of Washington, Seattle, Washington 98195,3
Fred Hutchinson Cancer Research Center, Seattle, Washington 981094
Received 7 March 2002/
Accepted 26 July 2002
Although human immunodeficiency virus type 1 (HIV-1) recombinants have been found with high frequency, little is known about the forces that select for these viruses or their importance to pathogenesis. Here we document the emergence and dynamics of 11 distinct HIV-1 recombinants in a man who was infected with two subtype B HIV-1 strains and progressed rapidly to AIDS without developing substantial cellular or humoral immune responses. Although numerous frequency oscillations were observed, a single recombinant lineage eventually came to dominate the population. Numerical simulations indicate that the successive recombinant forms displaced each other too rapidly to be explained by any simple model of random genetic drift or sampling variation. All of the recombinants, including several resulting from independent recombination events, possessed the same sequence motif in the V3 loop, suggesting intense selection on this segment of the viral envelope protein. The outgrowth of the predominant V3 loop recombinants was not, however, associated with changes in coreceptor utilization. The final variant was instead notable for having lost 3 of 14 potential glycosylation sites. We also observed high ratios of synonymous-to-nonsynonymous nucleotide changessuggestive of purifying selectionin all viral populations, with particularly high ratios in newly arising recombinants. Our study, therefore, illustrates the unusual and important patterns of viral adaptation that can occur in a patient with weak immune responses. Although it is hard to tease apart cause and effect in a single patient, the correlation with disease progression in this patient suggests that recombination between divergent viruses, with its ability to create chimeras with increased fitness, can accelerate progression to AIDS.
* Corresponding author. Mailing address: Department of Microbiology, University of Washington, Seattle, WA 98195. Phone: (206) 616-1851. Fax: (360) 838-9259. E-mail: jmullins{at}u.washington.edu.
Present addresses: Department of Pathology, University of Washington, Seattle, WA 98195, and Fred Hutchinson Cancer Research Center, Seattle, WA 98119.
Present address: Washington Regional Primate Research Center, Seattle, WA 98195.
Present address: School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Journal of Virology, November 2002, p. 10674-10684, Vol. 76, No. 21
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.21.10674-10684.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nora, T., Charpentier, C., Tenaillon, O., Hoede, C., Clavel, F., Hance, A. J.
(2007). Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment. J. Virol.
81: 7620-7628
[Abstract]
[Full Text]
-
Mild, M., Esbjornsson, J., Fenyo, E. M., Medstrand, P.
(2007). Frequent Intrapatient Recombination between Human Immunodeficiency Virus Type 1 R5 and X4 Envelopes: Implications for Coreceptor Switch. J. Virol.
81: 3369-3376
[Abstract]
[Full Text]
-
Chen, J., Powell, D., Hu, W.-S.
(2006). High Frequency of Genetic Recombination Is a Common Feature of Primate Lentivirus Replication. J. Virol.
80: 9651-9658
[Abstract]
[Full Text]
-
Casazza, J. P., Betts, M. R., Hill, B. J., Brenchley, J. M., Price, D. A., Douek, D. C., Koup, R. A.
(2005). Immunologic Pressure within Class I-Restricted Cognate Human Immunodeficiency Virus Epitopes during Highly Active Antiretroviral Therapy. J. Virol.
79: 3653-3663
[Abstract]
[Full Text]
-
Rhodes, T. D., Nikolaitchik, O., Chen, J., Powell, D., Hu, W.-S.
(2005). Genetic Recombination of Human Immunodeficiency Virus Type 1 in One Round of Viral Replication: Effects of Genetic Distance, Target Cells, Accessory Genes, and Lack of High Negative Interference in Crossover Events. J. Virol.
79: 1666-1677
[Abstract]
[Full Text]
-
Friedrich, T. C., McDermott, A. B., Reynolds, M. R., Piaskowski, S., Fuenger, S., de Souza, I. P., Rudersdorf, R., Cullen, C., Yant, L. J., Vojnov, L., Stephany, J., Martin, S., O'Connor, D. H., Wilson, N., Watkins, D. I.
(2004). Consequences of Cytotoxic T-Lymphocyte Escape: Common Escape Mutations in Simian Immunodeficiency Virus Are Poorly Recognized in Naive Hosts. J. Virol.
78: 10064-10073
[Abstract]
[Full Text]
-
Shriner, D., Rodrigo, A. G., Nickle, D. C., Mullins, J. I.
(2004). Pervasive Genomic Recombination of HIV-1 in Vivo. Genetics
167: 1573-1583
[Abstract]
[Full Text]
-
Pastore, C., Ramos, A., Mosier, D. E.
(2004). Intrinsic Obstacles to Human Immunodeficiency Virus Type 1 Coreceptor Switching. J. Virol.
78: 7565-7574
[Abstract]
[Full Text]
-
Reggeti, F., Bienzle, D.
(2004). Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol.
85: 1843-1852
[Abstract]
[Full Text]
-
Tsui, R., Herring, B. L., Barbour, J. D., Grant, R. M., Bacchetti, P., Kral, A., Edlin, B. R., Delwart, E. L.
(2004). Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following 215 Years of Injection Drug User Exposure. J. Virol.
78: 94-103
[Abstract]
[Full Text]
-
Pistello, M., Matteucci, D., Bonci, F., Isola, P., Mazzetti, P., Zaccaro, L., Merico, A., Del Mauro, D., Flynn, N., Bendinelli, M.
(2003). AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Protection from an Intraclade Challenge Administered Systemically or Mucosally by an Attenuated Vaccine. J. Virol.
77: 10740-10750
[Abstract]
[Full Text]
-
Rhodes, T., Wargo, H., Hu, W.-S.
(2003). High Rates of Human Immunodeficiency Virus Type 1 Recombination: Near-Random Segregation of Markers One Kilobase Apart in One Round of Viral Replication. J. Virol.
77: 11193-11200
[Abstract]
[Full Text]
-
Rangel, H. R., Weber, J., Chakraborty, B., Gutierrez, A., Marotta, M. L., Mirza, M., Kiser, P., Martinez, M. A., Este, J. A., Quinones-Mateu, M. E.
(2003). Role of the Human Immunodeficiency Virus Type 1 Envelope Gene in Viral Fitness. J. Virol.
77: 9069-9073
[Abstract]
[Full Text]
-
Altfeld, M., Addo, M. M., Shankarappa, R., Lee, P. K., Allen, T. M., Yu, X. G., Rathod, A., Harlow, J., O'Sullivan, K., Johnston, M. N., Goulder, P. J. R., Mullins, J. I., Rosenberg, E. S., Brander, C., Korber, B., Walker, B. D.
(2003). Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences. J. Virol.
77: 7330-7340
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.